Cargando…
Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center
BACKGROUND: Left Ventricular Assist Device (LVAD) is a promising therapy for patients with advanced heart failure (HF), but bleeding complications remain an important issue. Previous series show that acquired von Willebrand syndrome was present in up to 100 % of first generation LVAD recipients. We...
Autores principales: | Esmaeilzadeh, Fatemeh, Wauters, Aurélien, Wijns, Walter, Argacha, Jean-François, van de Borne, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969666/ https://www.ncbi.nlm.nih.gov/pubmed/27485105 http://dx.doi.org/10.1186/s12872-016-0334-z |
Ejemplares similares
-
Octreotide for the Management of Gastrointestinal Bleeding in a Patient with a HeartWare Left Ventricular Assist Device
por: Dang, Geetanjali, et al.
Publicado: (2014) -
Comparison of left ventricular geometry after HeartMate II and HeartWare left ventricular assist device implantation
por: Hosseini, Morteza Tavakkoli, et al.
Publicado: (2013) -
Early thrombus formation in patient with HeartWare left ventricular assist device presenting with acute heart failure
por: Ucar, Mustafa, et al.
Publicado: (2016) -
Evolution of thrombolytic therapy in patients with HeartWare ventricular assist device thrombosis: a single-institutional experience
por: Fox, Henrik, et al.
Publicado: (2022) -
Treatment of device thrombus in the HeartWare HVAD: surgical exchange through thoracotomy
por: Ghandour, Amale, et al.
Publicado: (2021)